 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Nitroglycerin, a drug that dilates blood vessels, is commonly used to relieve chest pain caused by coronary artery disease. It also relaxes the smooth muscles of vessels and can relieve chest pain from esophageal spasm. Because of its different actions, researchers wonder whether relief of acute chest pain with nitroglycerin reliably indicates that pain was caused by coronary disease.
SUMMARIES FOR PATIENTS
Does Chest Pain Relief with Nitroglycerin Mean Coronary Artery Disease?
16 December 2003 | Volume 139 Issue 12 | Page I-30
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "Chest Pain Relief by Nitroglycerin Does Not Predict Active Coronary Artery Disease." It is in the 16 December 2003 issue of Annals of Internal Medicine (volume 139, pages 979-986). The authors are C.A. Henrikson, E.E. Howell, D.E. Bush, J.S. Miles, G.R. Meininger, T. Friedlander, A.C. Bushnell, and N. Chandra-Strobos.
What is the problem and what is known about it so far?
Chest pain is a common symptom that can be caused by several conditions. Cardiac causes of chest pain, such as angina and heart attack, are serious and usually require prompt medical attention and treatment. Other causes of chest pain, such as spasm of the esophagus or inflammation of the chest wall, may be less serious and require different treatment than does chest pain related to heart conditions. Therefore, an accurate diagnosis is important to guide proper treatment of patients with chest pain.
Why did the researchers do this particular study?
To see whether pain relief by nitroglycerin correctly identifies patients with acute chest pain who have coronary artery disease.
Who was studied?
459 adults with acute chest pain who were admitted to an urban community teaching hospital through the emergency department.
How was the study done?
A health care provider gave nitroglycerin (spray or tablet under the tongue) to patients visiting the emergency department for evaluation of chest pain. Using a standard form, patients rated the severity of their chest pain immediately before and about 5 minutes after receiving nitroglycerin. The researchers labeled pain as relieved if there was a 50% or greater reduction in the intensity of chest pain. All patients were admitted to the hospital for further observation or tests to evaluate the presence of active coronary artery disease. The researchers called patients about 4 months after hospitalization and reviewed medical records to see whether any had died or had repeated hospitalizations, heart attacks, or heart procedures.
What did the researchers find?
Nitroglycerin relieved pain in 39% of all patients. It relieved pain in 35% of the patients who had subsequent evidence of active coronary disease. It relieved pain in 41% of the patients who had no subsequent evidence of active coronary disease. At 4 months, there were no major differences in outcomes between patients who did and did not have pain relieved by nitroglycerin.
What were the limitations of the study?
The doctors who were caring for the patients were aware of the reported responses to nitroglycerin. This may have influenced their decision to further test for coronary artery disease. Also, all patients didn't get the same tests to diagnose or exclude active coronary disease.
What are the implications of the study?
In emergency department settings, relief of chest pain with nitroglycerin does not help diagnose active coronary artery disease.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  S. E. Hofkamp, C. A. Henrikson, and S. T. Wegener An Interactive Model of Pain and Myocardial Ischemia Psychosom Med, September 1, 2007; 69(7): 632 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): 652 - 726. [Full Text] [PDF]
|
|
|
|
 |
|
 Part 5: Acute Coronary Syndromes Circulation, November 29, 2005; 112(22_suppl): III-55 - III-72. [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Swap and J. T. Nagurney Value and Limitations of Chest Pain History in the Evaluation of Patients With Suspected Acute Coronary Syndromes JAMA, November 23, 2005; 294(20): 2623 - 2629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Evans and B. M. Reilly Chest Pain Relief by Nitroglycerin Ann Intern Med, August 17, 2004; 141(4): 324 - 324. [Full Text] [PDF]
|
|
|
|
 |
|
 "The Pain Was Relieved by Nitro": Helpful Information? Journal Watch Gastroenterology, March 2, 2004; 2004(302): 8 - 8. [Full Text]
|
|
|
|
 |
|
 I. Malik JournalScan Heart, March 1, 2004; 90(3): 353 - 354. [Full Text] [PDF]
|
|
|
|
 |
|
 Does Nitroglycerin Response Have Diagnostic Value in the ER? Journal Watch Cardiology, February 13, 2004; 2004(213): 1 - 1. [Full Text]
|
|
|
|
 |
|
 Response to Nitroglycerin Does Not Predict an Ischemic Cause for Chest Pain Journal Watch Emergency Medicine, February 3, 2004; 2004(203): 1 - 1. [Full Text]
|
|
|
|
 |
|
 "The Pain Was Relieved by Nitro": Helpful Information? Journal Watch (General), January 16, 2004; 2004(116): 1 - 1. [Full Text]
|
|
|
|
|
|
R. J. Gibbons Nitroglycerin: Should We Still Ask? Ann Intern Med, December 16, 2003; 139(12): 1036 - 1037. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
